141 results
6-K
EX-99.1
LMNL
Liminal BioSciences Inc.
16 Aug 23
Current report (foreign)
9:25pm
the Company provide any assurance, that these conditions will be satisfied or, if satisfied, when they will be satisfied.
Each of the Purchaser … . Accordingly, there is no certainty, nor can the Company provide any assurance, that the Arrangement Agreement will not be terminated by either the Purchaser
6-K
EX-99.2
LMNL
Liminal BioSciences Inc.
8 Aug 23
Liminal BioSciences Reports Second Quarter Financial Results 2023
4:10pm
the necessary funding and further reduce the costs of our operations, there can be no assurance of our access to further funding on acceptable terms, if at all … or other sources.
Despite our efforts to obtain the necessary funding and improve profitability of its operations, there can be no assurance of its success
6-K
EX-99.3
LMNL
Liminal BioSciences Inc.
8 Aug 23
Liminal BioSciences Reports Second Quarter Financial Results 2023
4:10pm
the necessary funding and improve profitability of its operations, there can be no assurance of its success in doing so, especially with respect to its access
6-K
EX-99.5
LMNL
Liminal BioSciences Inc.
8 Aug 23
Liminal BioSciences Reports Second Quarter Financial Results 2023
4:10pm
of the period covered by the interim filings
A.designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance … ICFR, or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting
6-K
EX-99.4
LMNL
Liminal BioSciences Inc.
8 Aug 23
Liminal BioSciences Reports Second Quarter Financial Results 2023
4:10pm
covered by the interim filings
A.designed DC&P, or caused it to be designed under our supervision, to provide reasonable assurance that
I.material … , or caused it to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation
6-K
EX-99.1
0jumqyv0qfib0oco
12 Jul 23
Current report (foreign)
12:00am
6-K
EX-99.2
ain04dn4w1ti2pw2ty2
12 Jul 23
Current report (foreign)
12:00am
6-K
EX-99.2
96m8o68hja
9 May 23
Liminal BioSciences Reports First Quarter Financial Results 2023
4:10pm
6-K
EX-99.3
gfb6zq5y
9 May 23
Liminal BioSciences Reports First Quarter Financial Results 2023
4:10pm
6-K
EX-99.4
coqgko
9 May 23
Liminal BioSciences Reports First Quarter Financial Results 2023
4:10pm
6-K
EX-99.5
znfbex5e8i9rgwdr
9 May 23
Liminal BioSciences Reports First Quarter Financial Results 2023
4:10pm
6-K
EX-99.1
ulc1p34d045szb1o0l
8 May 23
Current report (foreign)
8:20am
6-K
EX-99.1
nftp6 z2x
5 Apr 23
Current report (foreign)
8:22am
6-K
EX-99.1
3cp7t2n05tgr
15 Dec 22
Notice of Special Meeting of Shareholders
4:03pm
6-K
EX-99.3
bne6ilxuvg
9 Nov 22
Liminal BioSciences Reports Third Quarter 2022 Financial Results and Business Highlights
4:11pm
6-K
EX-99.5
jqnxg4l63 4ydpbh
9 Nov 22
Liminal BioSciences Reports Third Quarter 2022 Financial Results and Business Highlights
4:11pm
6-K
EX-99.4
l2129
9 Nov 22
Liminal BioSciences Reports Third Quarter 2022 Financial Results and Business Highlights
4:11pm
6-K
EX-99.2
ohjgzdgchl4739c
9 Nov 22
Liminal BioSciences Reports Third Quarter 2022 Financial Results and Business Highlights
4:11pm
6-K
EX-99.2
bn3p82d0gp
10 Aug 22
Liminal BioSciences Reports Second Quarter 2022 Financial Results and Business Highlights
12:00am
6-K
EX-99.5
4y9br k15rqnpe
10 Aug 22
Liminal BioSciences Reports Second Quarter 2022 Financial Results and Business Highlights
12:00am